Circulation: Cardiovascular Interventions

JANUARY 22, 2025

Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many. If their transcatheter heart valve degenerates later in life, most will hope to undergo redo-TAVR.

TAVR 73

TAVR Aortic valve Aortic Stenosis 73

Frontiers in Cardiovascular Medicine

MARCH 9, 2025

Transcatheter aortic valve replacement (TAVR) has become a leading treatment for aortic stenosis, but managing thromboembolic and bleeding risks post-procedure remains challenging. This review examines current evidence on antithrombotic therapy after TAVR.

Aortic valve 52

Aortic valve Aortic TAVR Thrombosis 52

Med Page Today

APRIL 19, 2025

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

TAVR 83

TAVR Heart Failure Outcomes 83

Open Heart

FEBRUARY 27, 2024

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer. vs 74.7%, p=0.50).

Aortic valve 98

Aortic valve Cancer Aortic TAVR 98

CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The post SAVR’s Value in the TAVR Era appeared first on Cardiac Wire.

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

American College of Cardiology

OCTOBER 30, 2024

Several abstracts presented at TCT 2024, taking place Oct.

Chest Pain 55

Chest Pain Coronary Artery Disease TAVR Bicuspid/Mitral 55

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV).

Pacemaker 52

Pacemaker Aortic Stenosis Aortic valve 52

HCPLive

FEBRUARY 16, 2024

Tom Nguyen, MD, discusses a recent study he led comparing outcomes of TAVR explantation based on transcatheter heart valve type.

TAVR 59

TAVR Heart Valves Outcomes 59

American College of Cardiology

NOVEMBER 5, 2024

What are outcomes among patients younger than 65 years who received transcatheter aortic valve replacement (TAVR) using a balloon-expandable valve compared to patients aged 65-80 years?

TAVR 48

TAVR Aortic valve Outcomes Aortic 48

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

American College of Cardiology

JUNE 13, 2024

What are the rates of a permanent pacemaker (PPM) implantation, the predictors of needing a PPM, and long-term clinical outcomes of the third-generation balloon-expandable SAPIEN 3 (S3) transcatheter heart valve (THV)?

Pacemaker 68

Pacemaker TAVR Outcomes Heart Valves 68

American College of Cardiology

AUGUST 21, 2024

Among patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable valve (BEV), what are the 3-year clinical outcomes associated with a small (20 mm) compared to a larger (≥23 mm) device, and is there a relationship between the discharge echocardiographic (echo) mean gradient (MG) and measured or predicted thresholds (..)

TAVR 48

TAVR Aortic valve Outcomes Aortic 48

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement. These risks, combined with advanced age, significant co-morbidities, and a severely calcified small aortic annulus, supported the choice of TAVR with a self-expanding Acurate Neo2 valve.

Aortic valve 52

Aortic valve Aortic TAVR Myocardial Infarction 52

American College of Cardiology

APRIL 15, 2025

Real-world low-risk patients undergoing TAVR have a greater risk of adverse events at one year, particularly mortality, when compared with published clinical trial data, according to a study published April 3 in Circulation.

TAVR 48

TAVR Outcomes Circulation Article 48

American College of Cardiology

NOVEMBER 6, 2024

What are the contemporary characteristics, trends, and outcomes of intravascular lithotripsy (IVL)-assisted transfemoral (TF) transcatheter aortic valve replacement (TAVR) in the United States?

TAVR 43

TAVR Aortic valve Outcomes Aortic 43

American College of Cardiology

OCTOBER 21, 2024

Patients with moderate or severe tricuspid regurgitation (TR) prior to undergoing TAVR or mitral transcatheter edge-to-edge repair (TEER), when compared to patients with no or mild TR, were associated with worse health status and clinical outcomes, according to a study published in JACC: Cardiovascular Interventions.

TAVR 48

TAVR Bicuspid/Mitral Tricuspid Outcomes 48

Heart BMJ

JULY 10, 2024

Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning.

Aortic valve 98

Aortic valve Aortic Quality of Life TAVR 98

American College of Cardiology

DECEMBER 4, 2024

Does measured or predicted prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) affect all-cause mortality at 2 years?

TAVR 46

TAVR Aortic valve Outcomes Aortic 46

Society of Thoracic Surgeons - Congenital

APRIL 12, 2024

Resource SAVR After TAVR Risk Calculator kchalko Fri, 04/12/2024 - 13:53 SAVR after previous TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority of patients require explant of their TAVR device and SAVR with significantly increased risk of operative mortality and stroke.

TAVR 52

TAVR Patient Care Outcomes Research 52

American College of Cardiology

FEBRUARY 8, 2024

Is there a relationship between site-level volumes and outcomes for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER)?

TAVR 46

TAVR Aortic valve Outcomes Hospital 46

NEJM Journal Watch - Cardiology

FEBRUARY 22, 2024

Ten-year follow-up of an “all-comers” randomized trial demonstrates no difference in clinical outcomes between TAVR and SAVR.

Aortic valve 75

Aortic valve TAVR Outcomes Aortic 75

American College of Cardiology

MARCH 6, 2024

What are the hemodynamic and clinical outcomes after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis (AS) and a small aortic annulus?

TAVR 55

TAVR Aortic Stenosis Aortic valve 55

American College of Cardiology

AUGUST 14, 2024

What is the relationship between diffusion-weighted magnetic resonance imaging (DW-MRI) total lesion number (TLN), individual lesion volume (ILV), and total lesion volume (TLV) with clinical stroke outcomes after transcatheter aortic valve replacement (TAVR)?

TAVR 48

TAVR Aortic valve Aortic Strokes 48

American College of Cardiology

OCTOBER 28, 2024

Two separate late-breaking clinical trials – EARLY TAVR and EVOLVED – presented at TCT 2024 explore whether early aortic valve intervention improves outcomes in patients with asymptomatic aortic stenosis (AS).

TAVR 48

TAVR Aortic valve Aortic Stenosis 48

American College of Cardiology

NOVEMBER 6, 2024

In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients.

TAVR 48

TAVR Blood Pressure Aortic valve Aortic 48

Frontiers in Cardiovascular Medicine

MARCH 20, 2025

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral Stenosis 52

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients from a U.S.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

DAIC

JANUARY 29, 2024

These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer. Using the Society of Thoracic Surgeons Adult Cardiac Surgery Database , the study covers adult patients who underwent cardiac surgery after an initial TAVR from January 2012 to March 2023.

Research 111

Research TAVR Aortic valve Atrial Fibrillation 111

American College of Cardiology

JANUARY 6, 2025

Subclinical leaflet thrombosis (SLT) has raised concerns about the long-term durability and outcomes of transcatheter aortic valve replacement (TAVR). Clinical valve thrombosis (CVT) is a rare complication after TAVR with an incidence of 0.62.8%

Thrombosis 40

Thrombosis TAVR Aortic valve Aortic 40

American College of Cardiology

APRIL 7, 2024

The supra-annular self-expanding Evolut PRO/PRO+/FX TAVR device was found to be superior for valve function and noninferior for clinical outcomes at one year compared to the balloon-expandable SAPIEN 3/3 Ultra TAVR device, according to the results of the SMART trial, presented during a Late-Breaking Clinical Trial Session at ACC.24

TAVR 46

TAVR Outcomes Article 46

JAMA Cardiology

MAY 14, 2024

This cohort study examines whether there is an association between osteosarcopenia and adverse outcomes, such as increased risk of mortality, in older adults following transcatheter aortic valve replacement (TAVR).

Aortic valve 73

Aortic valve Aortic TAVR Outcomes 73

NEJM Journal Watch - Cardiology

APRIL 8, 2024

Another trial demonstrates substantial benefit with TAVR — at least for 1-year outcomes.

Aortic valve 75

Aortic valve TAVR Aortic Outcomes 75

Open Heart

APRIL 27, 2023

Background and aims Randomised controlled trials comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) were performed in highly selected populations and data regarding long-term secondary complications beyond mortality are scarce. Secondary outcomes included adverse outcomes and readmission.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Open Heart

JANUARY 31, 2022

Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

HCPLive

SEPTEMBER 20, 2024

As advancements in valvular technology progress, Nguyen highlights the need for long-term data and multidisciplinary collaboration to improve patient outcomes.

Aortic valve 64

Aortic valve TAVR Aortic Technology 64

Open Heart

JUNE 21, 2022

However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. Objective To understand the impact of elevated FP in patients with severe AS who undergo TAVR. Patients with elevated FP had a mean age of 81.2±8.6

Aortic valve 52

Aortic valve TAVR Aortic AFIB 52

American College of Cardiology

APRIL 22, 2025

Reardon delve into the 5-year results from the Evolut Low-Risk randomized trial, offering valuable insights about the future of TAVR and its impact on patient care. In this episode, Drs. Chazal and Michael J.

TAVR 48

TAVR Outcomes Patient Care Article 48